These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8819118)

  • 1. The eighth mystery of acquired immune deficiency syndrome and the "Trojan horse' mechanism.
    Erlander SR
    Med Hypotheses; 1996 Jul; 47(1):55-64. PubMed ID: 8819118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The solution to the seven mysteries of AIDS: the 'Trojan horse'.
    Erlander SR
    Med Hypotheses; 1995 Jan; 44(1):1-9. PubMed ID: 7776895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High turnover of HIV in blood revealed by new studies.
    Cohen J
    Science; 1995 Jan; 267(5195):179. PubMed ID: 7809623
    [No Abstract]   [Full Text] [Related]  

  • 4. Update on HIV transmission and pathogenesis.
    Gozlan M
    Lancet; 1995 Nov; 346(8985):1290. PubMed ID: 7475727
    [No Abstract]   [Full Text] [Related]  

  • 5. AIDS pathogenesis: from models to viral dynamics in patients.
    Nowak MA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S1-5. PubMed ID: 8595501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble human leukocyte antigen-G serum levels in patients with acquired immune deficiency syndrome affected by different disease-defining conditions before and after antiretroviral treatment.
    Murdaca G; Contini P; Setti M; Cagnati P; Spanò F; Lantieri F; Puppo F
    Hum Immunol; 2011 Sep; 72(9):712-6. PubMed ID: 21663783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replication.
    de Jong MD; Vella S; Carr A; Boucher CA; Imrie A; French M; Hoy J; Sorice S; Pauluzzi S; Chiodo F; Weverling GJ; van der Ende ME; Frissen PJ; Weigel HM; Kauffmann RH; Lange JM; Yoon R; Moroni M; Hoenderdos E; Leitz G; Cooper DA; Hall D; Reiss P
    J Infect Dis; 1997 Apr; 175(4):966-70. PubMed ID: 9086161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed cell death as a mechanism of CD4 and CD8 T cell deletion in AIDS. Molecular control and effect of highly active anti-retroviral therapy.
    Gougeon ML; Montagnier L
    Ann N Y Acad Sci; 1999; 887():199-212. PubMed ID: 10668476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of a model for the pathogenesis of AIDS.
    Stilianakis NI; Dietz K; Schenzle D
    Math Biosci; 1997 Oct; 145(1):27-46. PubMed ID: 9271894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal-associated lymphoid tissue immune reconstitution in a randomized clinical trial of raltegravir versus non-nucleoside reverse transcriptase inhibitor-based regimens.
    Asmuth DM; Ma ZM; Mann S; Knight TH; Yotter T; Albanese A; Melcher GP; Troia-Cancio P; Hayes T; Miller CJ; Pollard RB
    AIDS; 2012 Aug; 26(13):1625-34. PubMed ID: 22820612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protease inhibitors are effective only on HIV-infected cells].
    Fortschr Med; 1996 May; 114(15):12. PubMed ID: 8767934
    [No Abstract]   [Full Text] [Related]  

  • 12. Acquired immune deficiency syndrome: the glucocorticoid solution.
    Corley PA
    Med Hypotheses; 1996 Jul; 47(1):49-54. PubMed ID: 8819117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fight to the death.
    Short N
    Nat Med; 1995 Feb; 1(2):122-4. PubMed ID: 7585006
    [No Abstract]   [Full Text] [Related]  

  • 14. NIAID researchers present new findings at retrovirus meeting. National Institute of Allergy and Infectious Diseases.
    Doepel L; Folkers G
    NIAID AIDS Agenda; 1997 Mar; ():4, 11. PubMed ID: 11364173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel in the treatment of human immunodeficiency virus 1-associated Kaposi's sarcoma--drug-drug interactions with protease inhibitors and a nonnucleoside reverse transcriptase inhibitor: a case report study.
    Nannan Panday VR; Hoetelmans RM; van Heeswijk RP; Meenhorst PL; Inghels M; Mulder JW; Beijnen JH
    Cancer Chemother Pharmacol; 1999; 43(6):516-9. PubMed ID: 10321513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
    Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
    J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Virus-induced immune deficiency disease AIDS: direct pathogenic effect of the virus or immunopathology?].
    Zinkernagel R
    Verh Dtsch Ges Pathol; 1994; 78():166-70. PubMed ID: 7533980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives on inducing efficient immune control of HIV-1 replication--a new goal for HIV therapeutics?
    Bucy RP; Kilby JM
    AIDS; 2001 Feb; 15 Suppl 2():S36-42. PubMed ID: 11424975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection.
    Martínez E; Arnaiz JA; Podzamczer D; Dalmau D; Ribera E; Domingo P; Knobel H; Riera M; Pedrol E; Force L; Llibre JM; Segura F; Richart C; Cortés C; Javaloyas M; Aranda M; Cruceta A; de Lazzari E; Gatell JM;
    N Engl J Med; 2003 Sep; 349(11):1036-46. PubMed ID: 12968087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine modulation of HIV expression.
    Poli G; Fauci AS
    Semin Immunol; 1993 Jun; 5(3):165-73. PubMed ID: 7688596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.